Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huanrong Bai

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Patents|October 25, 2024
Menin-MLL protein-protein interaction inhibitors: a patent review (2021-present)Fang Wang, Zhe Yang, Yujie Wu, et al.
Expert Opinion on Therapeutic Patents|February 24, 2022
Menin-MLL protein-protein interaction inhibitors: a patent review (2014-2021)Huanrong Bai, San-Qi Zhang, Hao Lei, et al.
Drug Development Research|September 21, 2023
Discovery of novel pyrido[3,2-d]pyrimidine derivatives as selective and potent PI3Kδ inhibitorsHuanrong Bai, Jiajia Sun, Hao Lei, et al.
Journal of Medicinal Chemistry|September 29, 2022
Discovery of Novel, Potent, and Selective Small-Molecule Menin-Mixed Lineage Leukemia Interaction Inhibitors through Attempting Introduction of Hydrophilic GroupsHao Lei, San-Qi Zhang, Huanrong Bai, et al.
European Journal of Medicinal Chemistry|July 3, 2021
Small molecule selenium-containing compounds: Recent development and therapeutic applicationsHongyan Chuai, San-Qi Zhang, Huanrong Bai, et al.
European Journal of Medicinal Chemistry|February 17, 2024
Discovery of novel pyrrolo[2,3-d]pyrimidines as potent menin-mixed lineage leukemia interaction inhibitorsHuanrong Bai, Zhe Yang, Hao Lei, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|October 25, 2024
Menin-MLL protein-protein interaction inhibitors: a patent review (2021-present)Fang Wang, Zhe Yang, Yujie Wu, et al.
Expert Opinion on Therapeutic Patents|February 24, 2022
Menin-MLL protein-protein interaction inhibitors: a patent review (2014-2021)Huanrong Bai, San-Qi Zhang, Hao Lei, et al.
Drug Development Research|September 21, 2023
Discovery of novel pyrido[3,2-d]pyrimidine derivatives as selective and potent PI3Kδ inhibitorsHuanrong Bai, Jiajia Sun, Hao Lei, et al.
Journal of Medicinal Chemistry|September 29, 2022
Discovery of Novel, Potent, and Selective Small-Molecule Menin-Mixed Lineage Leukemia Interaction Inhibitors through Attempting Introduction of Hydrophilic GroupsHao Lei, San-Qi Zhang, Huanrong Bai, et al.
European Journal of Medicinal Chemistry|July 3, 2021
Small molecule selenium-containing compounds: Recent development and therapeutic applicationsHongyan Chuai, San-Qi Zhang, Huanrong Bai, et al.
European Journal of Medicinal Chemistry|February 17, 2024
Discovery of novel pyrrolo[2,3-d]pyrimidines as potent menin-mixed lineage leukemia interaction inhibitorsHuanrong Bai, Zhe Yang, Hao Lei, et al.
Pageof 1